Senior insider sale
Interim CFO at DAMORA THERAPEUTICS, INC. — senior position signals high conviction
$254.8K
9.66K shares
What this filing means
FIRMANI LORI plans to sell 9.66K shares of DAMORA THERAPEUTICS, INC. valued at approximately $254.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/6/2026ACC: 0001970051-26-000018
Officer· Interim CFO
Since Aug 2024
9.66K
Shares to sell
$254.8K
Approx. market value
1.80K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months2
Option
CASH
1/4/2023
1.10KOption
CASH
1/4/2023
703.00Total acquired1.80K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2023 | Option CASH | 1.10K | — |
1/4/2023 | Option CASH | 703.00 | — |
| Total | 1.80K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.62K
Market value
$192.9K
6/22/2026
—Completed
Units to sell
242.00
Market value
$5.9K
5/19/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.80K
Market value
$56.0K
8/5/2026
Total
Units
9.66K
Value
$254.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 7.62K | $192.9K | — | Completed |
5/19/2026 | 242.00 | $5.9K | — | Completed |
| Planned — Approximate Date | ||||
8/5/2026 | 1.80K | $56.0K | NASDAQ | Planned |
| Total | 9.66K | $254.8K | ||